Discussed are the new IMWG Criteria in MRD testing in multiple myeloma, which is to be published in Lancet Oncology. Attention is given as to how to use the testing going forward with patient care.

IMWG Myeloma Experts debate the latest trends in treatment
June 9, 2016
Copenhagen, Denmark

Previous Post
IMWG Conference Series - Copenhagen 2016: Is maintenance a standard of care?
Next Post
IMWG Conference Series - Copenhagen 2016: Are you proactive regarding your patients’ comorbidities?

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.